Need to be sold on the compelling reasons/benefits why i will now have a third of my exposure in Sundance diluted into Gindalbie.Not interested in Gindalbie and its' assets.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%